Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 03:40PM GMT
Release Date Price: $68 (-0.60%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Welcome to the first morning of the BofA Healthcare Conference. My name is Geoff Meacham. I'm a senior biopharma analyst, and we are excited to have Bristol-Myers here. And Adam Lenkowsky is here, who recently was promoted to EVP, Head of Commercial. So congratulations.

Adam Lenkowsky
Bristol-Myers Squibb Company - Executive VP, Chief Commercialization Officer & Head of U.S. Oncology

Thank you, Geoff. Great to be here.

Questions & Answers

Geoffrey Christopher Meacham;Adam Lenkowsky
BofA Securities, Research Division - Research Analyst;Bristol-Myers Squibb Company - Executive

Let's just kick off with that. Like so give us -- as you evolve into the new role, you already know a lot of the commercial business around the world and different therapeutic areas. Give us kind of your -- what would be your top 3 kind of list of priorities as you look to the back half of this year and into next?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot